UK PACS Study Finds Surprising Performance Variances

Published on:

Orem, Utah, April 16, 2013 -- KLAS study finds that the requirement to work through licensed service providers (LSPs) is causing incumbent PACS to be commonly perceived as inferior to newer entrants into the market. The report entitled UK PACS 2013: The View Is Changing looks at leading PACS suppliers and finds that incumbent PACS and newer PACS have closer performance scores than commonly perceived when not delivered through LSPs.

"This is a critical time for PACS," said report author Ben Brown. "One of the findings of the study is that 39 percent of providers in the UK are looking to replace their current PACS. This report looks at comparing the true performances of suppliers with and without LSPs. Some of the findings will surprise healthcare providers."

The report looked at offerings from Agfa, Carestream, FUJIFILM, GE and Sectra and compares performance, mindshare and likelihood to gain or lose market share. The report also looks at the growing RIS and VNA markets.

For more details on each vendor's performance and the KLAS report UK PACS 2013: The View Is Changing, visit KLAS online at www.KLASresearch.com/reports. The report is available to healthcare providers and suppliers. Providers receive a significant discount off the standard retail price or can receive a complimentary summary report in exchange for a survey of one of their current vendors.

 About KLAS
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch

Related Content

Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Rads are more accurate when they have access to patients' self-reported symptoms
AI-based software improves follow-up imaging adherence by 74%

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.